DP-109

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDP-109
Drug Alias NameBAPTA analog (D-Pharm)DP-109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium metabolism modulatorsApoptosis modulatorsChelating agents +[4] 
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesD-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD-Pharm Ltd
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A